Abiopharma

🔍 Kleinerman Christian (Executive)

Company: Snowflake Inc. (SNOW)

Report Date: 2026-03-20

Detailed Transactions and Holdings:

• Sold 1,793 shares of Common Stock at $175.4 per share (Direct)
  Date: 2026-03-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 494,259.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 860 shares of Common Stock at $175.4 per share (Direct)
  Date: 2026-03-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 493,399.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 42,716 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: A | equity_swap_involved: 0 | shares_owned_after: 536,115.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Sold 2,621 shares of Common Stock at $170.01 per share (Direct)
  Date: 2026-03-23 | Code: S | equity_swap_involved: 0 | shares_owned_after: 533,494.00 | transaction_form_type: 4 | Footnotes: F4, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: H | nature_of_ownership: LLC | shares_owned_after: 38,568.00 | Footnotes: F5
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: H | nature_of_ownership: LLC | shares_owned_after: 5,086.00 | Footnotes: F6
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: H | nature_of_ownership: 2023 GRAT | shares_owned_after: 32,716.00 | Footnotes: F7
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: H | nature_of_ownership: 2024 GRAT | shares_owned_after: 85,085.00 | Footnotes: F8
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-03-20 | Code: H | nature_of_ownership: 2025 GRAT | shares_owned_after: 100,000.00 | Footnotes: F9

Footnotes:

• F1: Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.
• F2: Includes shares to be issued in connection with the vesting of one or more restricted stock units.
• F3: The shares represent restricted stock units, which will vest quarterly over four years with 6.25% vesting on June 15, 2026 and on each Quarterly Vest Date thereafter, subject to the Reporting Person's continuous service through each such vesting date. Quarterly Vest Dates are each of March 15, June 15, September 15, and December 15.
• F4: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 19, 2024.
• F5: Shares are held by the Kleinerman 2020 Dynasty LLC for which the Reporting Person is the manager and the Reporting Person's immediate family members are the beneficiaries.
• F6: Shares are held by the Kleinerman 2020 Nonexempt LLC for which the Reporting Person is the manager and the Reporting Person's immediate family members are the beneficiaries of a trust that is the sole member.
• F7: Shares are held by the Christian Kleinerman 2023 Grantor Retained Annuity Trust dated September 1, 2023 for which the Reporting Person is the trustee.
• F8: Shares are held by the Christian Kleinerman 2024 Grantor Retained Annuity Trust dated December 20, 2024 for which the Reporting Person is the trustee.
• F9: Shares are held by the Christian Kleinerman 2025 Grantor Retained Annuity Trust dated December 14, 2025 for which the Reporting Person is the trustee.